146 related articles for article (PubMed ID: 33368014)
1. Abundance and Associated Variations of Cytochrome P450 Drug-Metabolizing Enzymes in the Liver of East Asian Adults: A Meta-Analysis.
An XX; Yu Y; Li GF; Yu G
Eur J Drug Metab Pharmacokinet; 2021 Mar; 46(2):225-233. PubMed ID: 33368014
[TBL] [Abstract][Full Text] [Related]
2. Absolute Quantitation of Drug-Metabolizing Cytochrome P450 Enzymes and Accessory Proteins in Dog Liver Microsomes Using Label-Free Standard-Free Analysis Reveals Interbreed Variability.
Martinez SE; Shi J; Zhu HJ; Perez Jimenez TE; Zhu Z; Court MH
Drug Metab Dispos; 2019 Nov; 47(11):1314-1324. PubMed ID: 31427433
[TBL] [Abstract][Full Text] [Related]
3. Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes.
Yang J; He MM; Niu W; Wrighton SA; Li L; Liu Y; Li C
Br J Clin Pharmacol; 2012 Feb; 73(2):268-84. PubMed ID: 21815912
[TBL] [Abstract][Full Text] [Related]
4. Impact of Ethnicity-Specific Hepatic Microsomal Scaling Factor, Liver Weight, and Cytochrome P450 (CYP) 1A2 Content on Physiologically Based Prediction of CYP1A2-Mediated Pharmacokinetics in Young and Elderly Chinese Adults.
Li GF; Zheng QS; Yu Y; Zhong W; Zhou HH; Qiu F; Wang G; Yu G; Derendorf H
Clin Pharmacokinet; 2019 Jul; 58(7):927-941. PubMed ID: 30767128
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics.
Achour B; Russell MR; Barber J; Rostami-Hodjegan A
Drug Metab Dispos; 2014 Apr; 42(4):500-10. PubMed ID: 24408517
[TBL] [Abstract][Full Text] [Related]
7. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
[TBL] [Abstract][Full Text] [Related]
8. Interindividual variations in levels and activities of cytochrome P-450 in liver microsomes of Chinese subjects.
Shu Y; Cheng ZN; Liu ZQ; Wang LS; Zhu B; Huang SL; Ou-Yang DS; Zhou HH
Acta Pharmacol Sin; 2001 Mar; 22(3):283-8. PubMed ID: 11742579
[TBL] [Abstract][Full Text] [Related]
9. Expression of hepatic drug-metabolizing cytochrome p450 enzymes and their intercorrelations: a meta-analysis.
Achour B; Barber J; Rostami-Hodjegan A
Drug Metab Dispos; 2014 Aug; 42(8):1349-56. PubMed ID: 24879845
[TBL] [Abstract][Full Text] [Related]
10. Multiplex and Label-Free Relative Quantification Approach for Studying Protein Abundance of Drug Metabolizing Enzymes in Human Liver Microsomes Using SWATH-MS.
Jamwal R; Barlock BJ; Adusumalli S; Ogasawara K; Simons BL; Akhlaghi F
J Proteome Res; 2017 Nov; 16(11):4134-4143. PubMed ID: 28944677
[TBL] [Abstract][Full Text] [Related]
11. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
[TBL] [Abstract][Full Text] [Related]
12. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
[TBL] [Abstract][Full Text] [Related]
13. Differences in cytochrome p450-mediated pharmacokinetics between chinese and caucasian populations predicted by mechanistic physiologically based pharmacokinetic modelling.
Barter ZE; Tucker GT; Rowland-Yeo K
Clin Pharmacokinet; 2013 Dec; 52(12):1085-100. PubMed ID: 23818090
[TBL] [Abstract][Full Text] [Related]
14. Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.
Venkatakrishnan K; von Moltke LL; Court MH; Harmatz JS; Crespi CL; Greenblatt DJ
Drug Metab Dispos; 2000 Dec; 28(12):1493-504. PubMed ID: 11095589
[TBL] [Abstract][Full Text] [Related]
15. Estimation of fractions metabolized by hepatic CYP enzymes using a concept of inter-system extrapolation factors (ISEFs) - a comparison with the chemical inhibition method.
Umehara KI; Huth F; Gu H; Schiller H; Heimbach T; He H
Drug Metab Pers Ther; 2017 Dec; 32(4):191-200. PubMed ID: 29176011
[TBL] [Abstract][Full Text] [Related]
16. Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.
Gao J; Wang J; Gao N; Tian X; Zhou J; Fang Y; Zhang HF; Wen Q; Jia LJ; Zou D; Qiao HL
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054967
[TBL] [Abstract][Full Text] [Related]
17. Postmortem protein stability investigations of the human hepatic drug-metabolizing cytochrome P450 enzymes CYP1A2 and CYP3A4 using mass spectrometry.
Hansen J; Palmfeldt J; Pedersen KW; Funder AD; Frost L; Hasselstrøm JB; Jornil JR
J Proteomics; 2019 Mar; 194():125-131. PubMed ID: 30529742
[TBL] [Abstract][Full Text] [Related]
18. CYP3A5 Contributes significantly to CYP3A-mediated drug oxidations in liver microsomes from Japanese subjects.
Yamaori S; Yamazaki H; Iwano S; Kiyotani K; Matsumura K; Honda G; Nakagawa K; Ishizaki T; Kamataki T
Drug Metab Pharmacokinet; 2004 Apr; 19(2):120-9. PubMed ID: 15499178
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 Pig liver pie: determination of individual cytochrome P450 isoform contents in microsomes from two pig livers using liquid chromatography in conjunction with mass spectrometry [corrected].
Achour B; Barber J; Rostami-Hodjegan A
Drug Metab Dispos; 2011 Nov; 39(11):2130-4. PubMed ID: 21795467
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
